Email ID
Password
Sign me in automatically next time
clinica
Featured
24 April 2014

 
24 April 2014
Just over a month after saying it was going public again , Biomet is now to be acquired by number-three orthopedic player Zimmer for $13.35bn in a combination of cash and stock. Warsaw, Indiana-based Biomet was ranked number 6 in Clinica’s Top 20 ...
24 April 2014
In the latest Inside China column, Michael Alper of NeuvoMedica details changes to China’s medical device regulation, and how the latest legislation might hint at future amendments Recently, China’s State Council released the much-awaited updated ...
24 April 2014
EU manufacturers may wish to consider phasing out the use of PVC in the manufacture of their medical devices, or risk exorbitant costs linked to unannounced audits by notified bodies in far flung places. That is the view of Andy Vaughan, consultant ...
23 April 2014
Over half of non-compliance issues among the member companies of the European Association for Medical Devices of Notified Bodies (TEAM-NB) are related to qualification and assignment of NB assessment personnel. That is the main eye-catching finding ...
 
24 April 2014
Just over a month after saying it was going public again , Biomet is now to be acquired by number-three orthopedic player Zimmer for $13.35bn in a combination of cash and stock. Warsaw, Indiana-based Biomet was ranked number 6 in Clinica’s Top 20 ...
24 April 2014
Contrary to the trend of medtech companies falling short of their IPO hopes, spinal device specialist K2M has increased the target for its initial public offering. The company said in March that it was hoping to raise $100m – but is now aiming for ...
22 April 2014
In spite of fears the medtech IPO window is closing, a couple more companies have taken their chances on the public markets. First, bio-artificial liver developer Vital Therapies has managed to raise $54m and float on the Nasdaq under the ticker ...
22 April 2014
Medtronic has got a reprieve, at least for now, in its ongoing legal battle with transcatheter aortic valve implant (TAVI) rival Edwards Lifesciences. In the latest twist, the appeals court has postponed an injunction granted to Edwards earlier this ...
 
24 April 2014
Just over a month after saying it was going public again , Biomet is now to be acquired by number-three orthopedic player Zimmer for $13.35bn in a combination of cash and stock. Warsaw, Indiana-based Biomet was ranked number 6 in Clinica’s Top 20 ...
24 April 2014
Contrary to the trend of medtech companies falling short of their IPO hopes, spinal device specialist K2M has increased the target for its initial public offering. The company said in March that it was hoping to raise $100m – but is now aiming for ...
24 April 2014
Genome sequencing specialist Illumina’s share price jumped after it posted 27% sales growth during its first fiscal quarter. Its stock closed up 5% at $147.98 on 22 April, the day it reported the results, and climbed another 4% to close at $153.69 ...
23 April 2014
Robotic surgery specialist Intuitive Surgical’s rough patch continues: its first-quarter sales fell 24% to $464.7m, also short of Canaccord Genuity analyst Jason Mills’ prediction of $567m. He wrote: “We had predicted a bumpy ride for Intuitive ...
 
24 April 2014
In the latest Inside China column, Michael Alper of NeuvoMedica details changes to China’s medical device regulation, and how the latest legislation might hint at future amendments Recently, China’s State Council released the much-awaited updated ...
24 April 2014
EU manufacturers may wish to consider phasing out the use of PVC in the manufacture of their medical devices, or risk exorbitant costs linked to unannounced audits by notified bodies in far flung places. That is the view of Andy Vaughan, consultant ...
23 April 2014
Over half of non-compliance issues among the member companies of the European Association for Medical Devices of Notified Bodies (TEAM-NB) are related to qualification and assignment of NB assessment personnel. That is the main eye-catching finding ...
17 April 2014
Improved effectiveness of radiation therapy and enhanced patient safety will be the outcomes of a new standard on radiation therapy (RT) treatments, issued last week by MITA, the US Medical Imaging & Technology Alliance. Specific technical “fail ...
 
Michael Lewis to chair Cambridge Cognition UK neuropsychological testing company Cambridge Cognition has appointed Michael Lewis nonexecutive chair, replacing Dr Jane Worlock, who is stepping ...
Fujifilm Sonosite makes Fujitani CEO Point-of-care ultrasound specialist Fujifilm Sonosite has appointed Naohiro Fujitani president and CEO after previous incumbent Kevin Goodwin stepped ...
Boston Scientific veteran to head up Pixium French retinal implant specialist Pixium has appointed Khalid Ishaque CEO – he joins from medtech giant Boston Scientific, where he has spent 17 ...
24 April 2014
Ashley Yeo

Many of the 250 plus delegates attending the Informa-IBI medtech networking and partnering meeting, IN3 Medical Device Conference 2014, in Dublin, Ireland, were celebrating a home-grown success at the event’s MedTech Idol contest. Day two of the ...

23 April 2014
Ashley Yeo

More help for medtech start-ups can never be a bad thing. This week former UK Home and Health Secretary Lord John Reid added his voice to the debate with a call to meet the transforming post-industrial society head on with more enterprise zones for ...

 
24 April 2014
Ashley Yeo

Many of the 250 plus delegates attending the Informa-IBI medtech networking and partnering meeting, IN3 Medical Device Conference 2014, in Dublin, Ireland, were celebrating a home-grown success at the event’s MedTech Idol contest. Day two of the ...

23 April 2014
Ashley Yeo

More help for medtech start-ups can never be a bad thing. This week former UK Home and Health Secretary Lord John Reid added his voice to the debate with a call to meet the transforming post-industrial society head on with more enterprise zones for ...

17 April 2014
Madeleine Armstrong

UK firm Proteome Sciences is hoping to take targeted medicine to a new level. The firm is developing technology to help identify which patients – potentially with any disease – will respond to certain drugs that could be just two years away from the ...

 
17 April 2014
Madeleine Armstrong

UK firm Proteome Sciences is hoping to take targeted medicine to a new level. The firm is developing technology to help identify which patients – potentially with any disease – will respond to certain drugs that could be just two years away from the ...

 
“Beyond Compliance”: a self regulation tool to add strength to the CE marking – podcast
16 December 2013
Get the Flash Player to see this player.
 

11 March 2013
Amanda Maxwell

The issue of informed consent for genetic tests dominated discussions at the European Parliament on February 26 during the second half of the meeting, dedicated to the European Commission’s proposed In Vitro Diagnostics Regulations. The tempo of the ...

 
31 May 2012
Hua Gong

Cancer diagnostics provide a promising future for unraveling the mystery of one of the leading killer diseases and helping to better detect and treat it. However, companies are currently facing a number of potential challenges when developing cancer ...

 
23 April 2014

Specialty area: Endovascular aneurysm repair Based in: Isnes, Belgium Founded in: 2002 No. of employees: 39 Total investment received to date: €15m Investors: Private investors

 
24 November 2011
Phil Greenfield

Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular ...

 
 
EVENTS
07 May 2014
Linz, AustriaVenue: Design Center LinzEuropaplatz 1, 4020 Linz, Austria http://www.design-center.at/
14 May 2014
Sheraton Brussels Hotel | Brussels | Belgium
14 May 2014
The Hotel. Brussels, Brussels, Belgium
 
© 2014 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36